Cargando…

Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy

OBJECTIVE: There is preliminary evidence that visceral fat area (VFA) was associated with the presence of type 2 diabetic peripheral neuropathy (DPN) in the Korean population; however, no studies have reported the association in Chinese population. The purpose of this study was to explore the possib...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yuru, Wan, Qin, Xu, Yong, Li, Jia, Li, Ke, Zhang, Zhihong, Tang, Qian, Miao, Ying, Yan, Pijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694982/
https://www.ncbi.nlm.nih.gov/pubmed/36439295
http://dx.doi.org/10.2147/DMSO.S388330
_version_ 1784837942592667648
author Wu, Yuru
Wan, Qin
Xu, Yong
Li, Jia
Li, Ke
Zhang, Zhihong
Tang, Qian
Miao, Ying
Yan, Pijun
author_facet Wu, Yuru
Wan, Qin
Xu, Yong
Li, Jia
Li, Ke
Zhang, Zhihong
Tang, Qian
Miao, Ying
Yan, Pijun
author_sort Wu, Yuru
collection PubMed
description OBJECTIVE: There is preliminary evidence that visceral fat area (VFA) was associated with the presence of type 2 diabetic peripheral neuropathy (DPN) in the Korean population; however, no studies have reported the association in Chinese population. The purpose of this study was to explore the possible correlation of VFA with DPN in such a population. METHODS: A total of 2498 hospitalized patients with type 2 diabetes mellitus (T2DM) undergone VFA measurement, and were divided into DPN group (n=900) and non-DPN group (n=1594). The association of VFA with the presence of DPN was evaluated by correlation and multiple logistic regression analyses, generalized additive model with a smooth curve fitting, and receiver operating characteristic (ROC) curve analysis. RESULTS: The VFA was significantly lower in the DPN group than in the non-DPN group (P < 0.001). VFA was significantly and positively associated with sural nerve conduction velocity (SNCV) and amplitude potential (SNAP) and negatively associated with the presence of DPN (all P< 0.001); there was no significant difference in the curve fitting (P = 0.344). Multivariate logistic regression analysis showed that the risk of presence of DPN decreased progressively across the VFA quartiles (P for trend < 0.001) and was significantly lower in patients in the highest VFA quartile than in those in the lowest quartile (OR: 0.382, 95% CI 0.151–0.968, P< 0.001) after multivariate adjustment. The ROC analysis revealed that the best cut-off value of VFA for predicting the presence of DPN was 50.5cm(2) (sensitivity 84.40%; specificity 34.00%). CONCLUSION: These results suggest that lower VFA level may be associated with increased risk of the presence of DPN in T2DM patients.
format Online
Article
Text
id pubmed-9694982
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-96949822022-11-26 Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy Wu, Yuru Wan, Qin Xu, Yong Li, Jia Li, Ke Zhang, Zhihong Tang, Qian Miao, Ying Yan, Pijun Diabetes Metab Syndr Obes Original Research OBJECTIVE: There is preliminary evidence that visceral fat area (VFA) was associated with the presence of type 2 diabetic peripheral neuropathy (DPN) in the Korean population; however, no studies have reported the association in Chinese population. The purpose of this study was to explore the possible correlation of VFA with DPN in such a population. METHODS: A total of 2498 hospitalized patients with type 2 diabetes mellitus (T2DM) undergone VFA measurement, and were divided into DPN group (n=900) and non-DPN group (n=1594). The association of VFA with the presence of DPN was evaluated by correlation and multiple logistic regression analyses, generalized additive model with a smooth curve fitting, and receiver operating characteristic (ROC) curve analysis. RESULTS: The VFA was significantly lower in the DPN group than in the non-DPN group (P < 0.001). VFA was significantly and positively associated with sural nerve conduction velocity (SNCV) and amplitude potential (SNAP) and negatively associated with the presence of DPN (all P< 0.001); there was no significant difference in the curve fitting (P = 0.344). Multivariate logistic regression analysis showed that the risk of presence of DPN decreased progressively across the VFA quartiles (P for trend < 0.001) and was significantly lower in patients in the highest VFA quartile than in those in the lowest quartile (OR: 0.382, 95% CI 0.151–0.968, P< 0.001) after multivariate adjustment. The ROC analysis revealed that the best cut-off value of VFA for predicting the presence of DPN was 50.5cm(2) (sensitivity 84.40%; specificity 34.00%). CONCLUSION: These results suggest that lower VFA level may be associated with increased risk of the presence of DPN in T2DM patients. Dove 2022-11-21 /pmc/articles/PMC9694982/ /pubmed/36439295 http://dx.doi.org/10.2147/DMSO.S388330 Text en © 2022 Wu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Wu, Yuru
Wan, Qin
Xu, Yong
Li, Jia
Li, Ke
Zhang, Zhihong
Tang, Qian
Miao, Ying
Yan, Pijun
Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy
title Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy
title_full Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy
title_fullStr Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy
title_full_unstemmed Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy
title_short Lower Visceral Fat Area in Patients with Type 2 Diabetic Peripheral Neuropathy
title_sort lower visceral fat area in patients with type 2 diabetic peripheral neuropathy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9694982/
https://www.ncbi.nlm.nih.gov/pubmed/36439295
http://dx.doi.org/10.2147/DMSO.S388330
work_keys_str_mv AT wuyuru lowervisceralfatareainpatientswithtype2diabeticperipheralneuropathy
AT wanqin lowervisceralfatareainpatientswithtype2diabeticperipheralneuropathy
AT xuyong lowervisceralfatareainpatientswithtype2diabeticperipheralneuropathy
AT lijia lowervisceralfatareainpatientswithtype2diabeticperipheralneuropathy
AT like lowervisceralfatareainpatientswithtype2diabeticperipheralneuropathy
AT zhangzhihong lowervisceralfatareainpatientswithtype2diabeticperipheralneuropathy
AT tangqian lowervisceralfatareainpatientswithtype2diabeticperipheralneuropathy
AT miaoying lowervisceralfatareainpatientswithtype2diabeticperipheralneuropathy
AT yanpijun lowervisceralfatareainpatientswithtype2diabeticperipheralneuropathy